|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
1993-9-2
|
|
pubmed:abstractText |
Reduced cardiac vagal tone in patients with myocardial infarction (MI) is associated with a high risk of sudden death. Muscarinic blocking agents in small doses induce a paradoxical increase in cardiac vagal activity in normal subjects. We tested whether low doses of scopolamine delivered transdermally enhance tonic and reflex cardiac vagal activity in patients in the acute phase of MI.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
0009-7322
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
88
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
353-7
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:8339398-Arteries,
pubmed-meshheading:8339398-Dose-Response Relationship, Drug,
pubmed-meshheading:8339398-Double-Blind Method,
pubmed-meshheading:8339398-Electrocardiography,
pubmed-meshheading:8339398-Female,
pubmed-meshheading:8339398-Heart Conduction System,
pubmed-meshheading:8339398-Humans,
pubmed-meshheading:8339398-Male,
pubmed-meshheading:8339398-Middle Aged,
pubmed-meshheading:8339398-Myocardial Infarction,
pubmed-meshheading:8339398-Pressoreceptors,
pubmed-meshheading:8339398-Reflex,
pubmed-meshheading:8339398-Scopolamine Hydrobromide,
pubmed-meshheading:8339398-Vagus Nerve
|
|
pubmed:year |
1993
|
|
pubmed:articleTitle |
Low doses of scopolamine increase cardiac vagal tone in the acute phase of myocardial infarction.
|
|
pubmed:affiliation |
Department of Cardiovascular Medicine, John Radcliffe Hospital, University of Oxford, England, UK.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
